Effect of Methyl-CpG binding domain protein 2 (MBD2) on AMD-like lesions in ApoE-deficient mice

Abstract

The role of methyl-CpG binding domain protein 2 (MBD2) in an ApoE-deficient mouse model of age-related macular degeneration (AMD) was investigated. Eight-week-old Mbd2/ApoE double deficient (Mbd2^-/- ApoE^-/-) mice (n=12, 24 eyes, experimental group) and MBD2 (wt) ApoE^-/- mice (n=12, 24 eyes, control group) were fed on Western-type diet for 4 months. The mice were sacrificed, and total serum cholesterol levels were analyzed and Bruch’s membrane (BM) of the eyes was removed for ultrastructural observation by transmission electron microscopy. Moreover, intercellular adhesion molecule 1 (ICAM-1) immunoreactivities were evaluated by fluorescence microscopy in sections of the eyes in both groups for further understanding the function mechanism of MBD2. There was no significant difference in the total serum cholesterol levels between control group and experimental group (P>0.05). Transmission electron microscopy revealed that AMD-like lesions, various vacuoles accumulated on BM, notable outer collagenous layer deposits and dilated basal infoldings of retinal pigment epithelium (RPE) were seen in both groups, and the BM in control group was significantly thickened as compared with experimental group (P<0.05). Fluorescence micrographs exhibited the expression of ICAM-1 in choroid was higher in control group than in experimental group. We are led to conclude that MBD2 gene knockout may lead to accumulation of more deposits on the BM and influence the pathogenesis of AMD via triggering endothelial activation and inflammatory response in choroid, improving microcirculation, and reducing lipid deposition so as to inhibit the development of AMD-like lesions. Our study helps to provide a new therapeutic approach for the clinical treatment of AMD.

Keywords

methyl-CpG binding domain protein 2 / aged-related macular degeneration / endothelial dysfunction / intercellular adhesion molecule 1

References

[1] LimLS, MitchellP, SeddonJM, et al.. Age-related macular degeneration. Lancet, 2012, 379(9827): 728-1738

[2] Zarbin MA. In: Bandello F, Querques G, eds. Medical Retina. Basel: Karger, 2012:125–133

[3] GorinMB. Genetic insights into age-related macular degeneration: controversies addressing risk, causality, and therapeutics. Mol Aspects Med, 2012, 33(4): 467-486

[4] WangY, WangVM, ChanCC. The role of anti-inflammatory agents in age-related macular degeneration (AMD) treatment. Eye (Lond), 2011, 25(2): 127-139

[5] MiaoH, TaoY, LiXX, et al.. Inflammatory cytokines in aqueous humor of patients with choroidal neovascularization. Mol Vis, 2012, 18: 574-580

[6] SkeieJM, HernandezJ, HinekA, et al.. Molecular responses of choroidal endothelial cells to elastin derived peptides through the elastin-binding protein (GLB1). Matrix Biol, 2012, 31(2): 113-119

[7] SwitzerDWJr, MendoncaLS, SaitoM, et al.. Segregation of ophthalmoscopic characteristics according to choroidal thickness in patients with early age-related macular degeneration. Retina, 2012, 32(7): 265-271

[8] DimitrovaG, KatoS. Color Doppler imaging of retinal diseases. Surv Ophthalmol, 2010, 55(3): 193-214

[9] DawsonMA, KouzaridesT. Cancer epigenetics: from mechanism to therapy. Cell, 2012, 150(1): 12-27

[10] GodfreyKM, SheppardA, GluckmanPD, et al.. Epigenetic gene promoter methylation at birth is associated with child’s later adiposity. Diabetes, 2011, 60(5): 1528-1534

[11] UdaliS, GuariniP, MoruzziS, et al.. Cardiovascular epigenetics: From DNA methylation to microRNAs. Mol Aspects Med, 2013, 34(4): 883-901

[12] CveklA, MittonKP. Epigenetic regulatory mechanisms in vertebrate eye development and disease. Heredity (Edinb), 2010, 105(1): 135-151

[13] ZhouP, LuoY, LiuX, et al.. Down-regulation and CpG island hypermethylation of CRYAA in age-related nuclear cataract. FASEB J, 2012, 26(12): 4897-4902

[14] WiggsJL. The cell and molecular biology of complex forms of glaucoma: updates on genetic, environmental, and epigenetic risk factors. Invest Ophthalmol Vis Sci, 2012, 53(5): 2467-2469

[15] ZhongQ, KowluruRA. Epigenetic changes in mitochondrial superoxide dismutase in the retina and the development of diabetic retinopathy. Diabetes, 2011, 60(4): 1304-1313

[16] YinX, LatifR, BahnRS, et al.. Genetic profiling in graves’ disease: further evidence for lack of a distinct genetic contribution to Graves’ ophthalmopathy. Thyroid, 2012, 22(7): 730-736

[17] TemmingP, CorsonTW, LohmannDR, et al.. Retinoblastoma tumorigenesis: genetic and epigenetic changes walk hand in hand. Future Oncol, 2012, 8(5): 525-528

[18] SuuronenT, NuutinenT, RyhanenT, et al.. Epigenetic regulation of clusterin/apolipoprotein J expression in retinal pigment epithelial cells. Biochem Biophys Res Commun, 2007, 357(2): 397-401

[19] HunterA, SpechlerPA, CwangerA, et al.. DNA methylation is associated with altered gene expression in AMD. Invest Ophthalmol Vis Sci, 2012, 53(4): 2089-2105

[20] RaoX, ZhongJ, ZhangS, et al.. Loss of methyl-CpG-binding domain protein 2 enhances endothelial angiogenesis and protects mice against hind-limb ischemic injury. Circulation, 2011, 123(25): 2964-2974

[21] Mares-PerlmanJA, BradyWE, KleinR, et al.. Dietary fat and age-related maculopathy. Arch Ophthalmol, 1995, 113(6): 743-748

[22] SinHP, LiuDT, LamDS, et al.. Lifestyle modification, nutritional and vitamins supplements for age-related macular degeneration. Acta Ophthalmol, 2013, 91(1): 6-11

[23] WeikelKA, ChiuCJ, TaylorA, et al.. Nutritional modulation of age-related macular degeneration. Mol Aspects Med, 2012, 33(4): 318-375

[24] WongIY, KooSC, ChanCW, et al.. Prevention of age-related macular degeneration. Int Ophthalmol, 2011, 31(1): 73-82

[25] NakashimaY, PlumpAS, RainesEW, et al.. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb Vasc Biol, 1994, 14(1): 133-140

[26] MalekG, JohnsonLV, MaceBE, et al.. Apolipoprotein E allele-dependent pathogenesis: a model for age-related retinal degeneration. Proc Natl Acad Sci U S A, 2005, 102(33): 1900-11905

[27] BhuttoI, LuttyG. Understanding age-related macular degeneration (AMD): relationships between the photoreceptor/retinal pigment epithelium/Bruch’s membrane/choriocapillaris complex. Mol Aspects Med, 2012, 33(4): 295-317

[28] KozlowskiMR. RPE cell senescence: a key contributor to age-related macular degeneration. Med Hypotheses, 2012, 78(4): 505-510

[29] MettuPS, WielgusAR, OngSS, et al.. Retinal pigment epithelium response to oxidant injury in the pathogenesis of early age-related macular degeneration. Mol Aspects Med, 2012, 33(4): 376-398

[30] HussainAA, LeeY, ZhangJJ, et al.. Disturbed matrix metalloproteinase activity of Bruch’s membrane in age-related macular degeneration. Invest Ophthalmol Vis Sci, 2011, 52(7): 4459-4466

[31] OngJM, ZorapapelNC, RichKA, et al.. Effects of cholesterol and apolipoprotein E on retinal abnormalities in ApoE-deficient mice. Invest Ophthalmol Vis Sci, 2001, 42(8): 1891-1900

[32] PennesiME, NeuringerM, CourtneyRJ, et al.. Animal models of age related macular degeneration. Mol Aspects Med, 2012, 33(4): 487-509

[33] DithmarS, CurcioCA, LeNA, et al.. Ultrastructural changes in Bruch’s membrane of apolipoprotein E-deficient mice. Invest Ophthalmol Vis Sci, 2000, 41(8): 2035-2042

[34] IdaH, IshibashiK, ReiserK, et al.. Ultrastructural aging of the RPE-Bruch’s membrane-choriocalpilaris complex in the D-galactose-treated mouse. Invest Ophthalmol Vis Sci, 2004, 45(7): 2348-2354

[35] MullinsRF, JohnsonMN, FaidleyEA, et al.. Choriocapillaris vascular dropout related to density of drusen in human eyes with early age-related macular degeneration. Invest Ophthalmol Vis Sci, 2011, 52(3): 1606-1612

[36] MachalinskaA, SafranowK, DziedziejkoV, et al.. Different populations of circulating endothelial cells in patients with age-related macular degeneration: a novel insight into pathogenesis. Invest Ophthalmol Vis Sci, 2011, 52(1): 93-100

[37] MachalinskaA, SafranowK, SylwestrzakZ, et al.. Elevated level of circulating endothelial cells as an exponent of chronic vascular dysfunction in the course of AMD. Klin Oczna, 2011, 113(7–9): 228-232

[38] GustavssonC, AgardhCD, ZetterqvistAV, et al.. Vascular cellular adhesion molecule-1 (VCAM-1) expression in mice retinal vessels is affected by both hyperglycemia and hyperlipidemia. PLoS One, 2010, 5(9): e12699

[39] MullinsRF, SkeieJM, MaloneEA, et al.. Macular and peripheral distribution of ICAM-1 in the human choriocapillaris and retina. Mol Vis, 2006, 30(12): 224-235

[40] BoltzA, LukschA, WimpissingerB, et al.. Choroidal blood flow and progression of age-related macular degeneration in the fellow eye in patients with unilateral choroidal neovascularization. Invest Ophthalmol Vis Sci, 2010, 51(8): 4220-4425

[41] BerenbergTL, MetelitsinaTI, MadowB, et al.. The association between drusen extent and foveolar choroidal blood flow in age-related macular degeneration. Retina, 2012, 32(1): 25

[42] NgHH, ZhangY, HendrichB, et al.. MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex. Nat Genet, 1999, 23(1): 58-61

[43] FatemiM, WadePA. MBD family proteins: reading the epigenetic code. J Cell Sci, 2006, 119(Pt15): 3033-3037

[44] KandaA, AbecasisG, SwaroopA, et al.. Inflammation in the pathogenesis of age-related macular degeneration. Br J Ophthalmol, 2008, 92(4): 448-450

[45] XuH, ChenM, ForresterJV, et al.. Para-inflammation in the aging retina. Prog Retin Eye Res, 2009, 28(5): 348-368

[46] FrankPG, LisantiMP. ICAM-1: role in inflammation and in the regulation of vascular permeability. Am J Physiol Heart Circ Physiol, 2008, 295(3): H926-H927

[47] LawsonC, WolfS. ICAM-1 signaling in endothelial cells. Pharmacol Rep, 2009, 61(1): 22-32

[48] PenfoldPL, WenL, MadiganMC, et al.. Modulation of permeability and adhesion molecule expression by human choroidal endothelial cells. Invest Ophthalmol Vis Sci, 2002, 43(9): 3125-3130

[49] Hafezi-Moghadam A. In: Joyce Tombran-Tink, Colin J. Barnstable, Thomas W, eds. Visual Dysfunction in Diabetes. New York: Springer, 2012:105–122

[50] SkeieJM, FingertJH, RussellSR, et al.. Complement component C5a activates ICAM-1 expression on human choroidal endothelial cells. Invest Ophthalmol Vis Sci, 2010, 51(10): 5336-5342